IRIS Biomedical’s parent Ripple supports Synchron’s successful First-In-Man BCI Study - Read More

About Us

Our mission is to provide best-in-class solutions for emerging neuromodulation and neurodiagnostic applications.

medical device manufacturing
medical device manufacturing

Neurotechnology for Advanced Medical Applications

IRIS Biomedical is a wholly owned subsidiary of Ripple Ventures established to provide neurotechnology engineering, and manufacturing services and technology licensing to the medical device industry.

MIRA 6

Company Info

As an original design manufacturer (ODM) IRIS has designed its core technology platform from the ground up to offer a range of sub-component and complete-system designs. IRIS specializes in high-performance closed-loop neural sensing and stimulation. We also offer a range of components for continuous wireless power delivery, inductive battery charging, data telemetry, and portable signal processing. Our designs have been rigorously field tested and can be easily adapted to a variety of form factors.

IRIS is an ideal technology partner for early-stage medical device companies without the budget or expertise to invest in developing a new device from the ground up. Our experienced engineering team and in-house clean-room facilities allow for rapid design development as well as prototype and early-stage commercial production.

IRIS helps companies develop best-in-class products and get to market first. IRIS follows national and international medical device regulations. All design and manufacturing work is performed under an ISO:13485-certified Quality Management System.

Company Info

As an original design manufacturer (ODM) IRIS has designed its core technology platform from the ground up to offer a range of sub-component and complete-system designs. IRIS specializes in high-performance closed-loop neural sensing and stimulation. We also offer a range of components for continuous wireless power delivery, inductive battery charging, data telemetry, and portable signal processing. Our designs have been rigorously field tested and can be easily adapted to a variety of form factors.

IRIS is an ideal technology partner for early-stage medical device companies without the budget or expertise to invest in developing a new device from the ground up. Our experienced engineering team and in-house clean-room facilities allow for rapid design development as well as prototype and early-stage commercial production.

IRIS helps companies develop best-in-class products and get to market first. IRIS follows national and international medical device regulations. All design and manufacturing work is performed under an ISO:13485-certified Quality Management System.

The Team Behind IRIS Biomedical

Andrew Wilder, PhD

Chief Executive Officer

Scott Hiatt

Chief Technology Officer

Alec Vogel

Quality & Operations Manager


Conferences

We attend a variety of industry events each year

Check the list below for a conference or event near you.

NANS 2021 (Mid-Year Meeting)

July 15-17, 2021 - Orlando, FL

Link: North American Neuromodulation Society

MD&M West 2021

Aug 10-12, 2021 - Anaheim, CA

Link: MD&M West

MD&M Minneapolis 2021

Nov 3-4, 2021 - Minneapolis, MN

Link: MD&M Minneapolis

BIOMEDevice 2021

Dec 8-9, 2021 - San Jose, CA

Link: BIOMEDevice Silicon Valley

NANS 2022

Jan 13-15, 2022 - Orlando, FL

Link: North American Neuromodulation Society

MD&M West 2022

April 12-14, 2022 - Anaheim, CA

Link: MD&M West

MD&M Minneapolis 2022

Nov 3-4, 2022 - Minneapolis, MN

Link: MD&M Minneapolis

IRIS BIOMEDICAL
Salt Lake City, Utah, 84106
© 2022 IRIS Biomedical

IRIS BIOMEDICAL
Salt Lake City, Utah, 84106
© 2022 IRIS Biomedical

Services
Contact